Feb 1 (Reuters) - Bristol-Myers Squibb Co
* Bristol-Myers Squibb announces European Patent Office decision on Sprycel
* Bristol-Myers Squibb Co says decision does not impact patents outside of EU or other Sprycel -related patents
* Bristol-Myers squibb co says EPO upheld a decision that found patent to be invalid Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.